MedPath

MERCK SHARP & DOHME (UK) LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

EMC:34
CIMA_AEMPS:23
NMPA:2

Drug Approvals

Belzutifan Tablets

Product Name
维利瑞
Approval Number
国药准字HJ20240135
Approval Date
Nov 15, 2024
NMPA

Molnupiravir Capsules

Product Name
利卓瑞
Approval Number
国药准字HJ20220097
Approval Date
Dec 29, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.